Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine
-
Add time:08/30/2019 Source:sciencedirect.com
Using a standard two-lever operant procedure with rats trained to discriminate 1-(3-trifluoromethylphenyl)piperazine (TFMPP) (0.5 mg/kg) from saline, tests of stimulus antagonism and stimulus generalization were performed to better understand the stimulus properties of this agent. The agents examined for ability to antagonize the TFMPP stimulus were prazosin, quipazine, zacopride, buspirone, 8-hydroxy-2-(di-N-propylamino) tetralin (8-OH-DPAT), 1-(2-methoxyphenol)-4-[4-(2-phthalimido)butyl]-piperazine (NAN-190), haloperidol, and 1-(2-pyrimidinyl)piperazine (1-PP); only buspirone attenuated the response to TF-MPP. In separate experiments, the lowest nondisrupting dose of buspirone (1.2 mg/kg) caused a rightward shift of the TFMPP dose-response curve (TFMPP alone, ED50 = 0.19 mg/kg; TEMPP + buspirone, ED50 = 0.43 mg/kg).. In addition, 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one (CP 93,129), 7-trifluoromethyl-4-(4-methyl-1-piperazinyl)pyrolo [1,2-a]quinoxaline (CGS 12066B), 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), 3-chlorophenylbiguanide (mCPBG), NAN-190, nisoxetine, zacopride, 1-PP, (+)-N-allylnormetazocine ((+)-NANM), and N-methyl31-(3,4-methylenedioxyphenyl)-2- aminopropane (MDMA) were analyzed in tests of stimulus generalization. The TFMPP stimulus generalized only to CGS 12066B (ED50 = 4.2 mg/kg) and (+)-NANM (ED50 = 8.8 mg/kg). Tests with DOI and MDMA resulted in partial generalization. Up to doses that disrupted behavior, all other agents had little effect on TFMPP-appropriate responding. The results of these and other published studies suggest roles for 5-hydroxytryptamine1B (5-HT1B), 5-HT1C, and, possibly, σ-receptors in the mediation of the TFMPP stimulus and indicate a lack of involvement of 5-HT1A, 5-HT2, dopaminergic, and adrenergic mechanisms in this behavior.
We also recommend Trading Suppliers and Manufacturers of N-(3-Trifluoromethylphenyl)piperazine (cas 15532-75-9). Pls Click Website Link as below: cas 15532-75-9 suppliers
Prev:Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment
Next:MDMA-like behavioral effects of N-substituted piperazines in the mouse) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Rapid communicationStimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol and mesulergine☆09/02/2019
- Original articleSynthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects09/01/2019
- MDMA-like behavioral effects of N-substituted piperazines in the mouse08/31/2019
- Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment08/29/2019
- Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models08/28/2019
- Mise au pointLa 1-benzylpipérazine (BZP) et la 1-(3-trifluorométhylphényl)pipérazine (TFMPP) : émergence de deux substances donnant lieu à un usage abusif1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): Emergence of two agents which lead to misuse08/27/2019
- Development of simultaneous gas chromatography–mass spectrometric and liquid chromatography–electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine08/26/2019
- ReviewPiperazine compounds as drugs of abuse08/25/2019
- ORIGINAL ARTICLEDevelopment of a targeted GC/MS screening method and validation of an HPLC/DAD quantification method for piperazines–amphetamines mixtures in seized material08/24/2019


